Literature DB >> 12172396

Physicians' propensity to offer genetic testing for Alzheimer's disease: results from a survey.

Gary A Chase1, Gail Geller, Suzanne L Havstad, Neil A Holtzman, Susan Spear Bassett.   

Abstract

PURPOSE: Examine physician knowledge, preferences, and use of genetic tests for Alzheimer's disease (AD).
METHODS: Survey of 426 community-based physicians treating AD patients.
RESULTS: Majority gave inaccurate estimates of AD risk. Medical specialty predicted appropriate use of current tests. Recommending substances to prevent memory loss was related to acceptance of error-free tests. High patient loads and familiarity with genetic tests predicted lower tolerance for test error.
CONCLUSION: Physicians do not endorse indiscriminate genetic susceptibility testing for AD. However, insufficient knowledge of disease risk, etiology, genetic susceptibility, and use of existing tests indicated a need for further physician education in this area.

Entities:  

Mesh:

Year:  2002        PMID: 12172396     DOI: 10.1097/00125817-200207000-00008

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  8 in total

1.  Consumer preferences for the predictive genetic test for Alzheimer disease.

Authors:  Ming-Yi Huang; Sally A Huston; Matthew Perri
Journal:  J Genet Couns       Date:  2013-07-12       Impact factor: 2.537

2.  A theory-informed systematic review of clinicians' genetic testing practices.

Authors:  Jean L Paul; Hanna Leslie; Alison H Trainer; Clara Gaff
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

3.  Perception on genetic testing in Korean medicine doctors: A mobile-based survey.

Authors:  Sunju Park; Seong-Cheon Woo; Hyo-Jeong Ban; Siwoo Lee; Song-Yi Kim; Hee-Jeong Jin
Journal:  Integr Med Res       Date:  2020-08-12

4.  The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.

Authors:  Robert Klitzman; Wendy Chung
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

5.  Disclosure of APOE genotype for risk of Alzheimer's disease.

Authors:  Robert C Green; J Scott Roberts; L Adrienne Cupples; Norman R Relkin; Peter J Whitehouse; Tamsen Brown; Susan LaRusse Eckert; Melissa Butson; A Dessa Sadovnick; Kimberly A Quaid; Clara Chen; Robert Cook-Deegan; Lindsay A Farrer
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

6.  Attitudes and practices among internists concerning genetic testing.

Authors:  Robert Klitzman; Wendy Chung; Karen Marder; Anita Shanmugham; Lisa J Chin; Meredith Stark; Cheng-Shiun Leu; Paul S Appelbaum
Journal:  J Genet Couns       Date:  2012-05-15       Impact factor: 2.537

Review 7.  Implementing dementia risk reduction in primary care: a preliminary conceptual model based on a scoping review of practitioners' views.

Authors:  Kali Godbee; Jane Gunn; Nicola T Lautenschlager; Eleanor Curran; Victoria J Palmer
Journal:  Prim Health Care Res Dev       Date:  2019-10-23       Impact factor: 1.458

8.  Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.

Authors:  Jill S Goldman; Susan E Hahn; Jennifer Williamson Catania; Susan LaRusse-Eckert; Melissa Barber Butson; Malia Rumbaugh; Michelle N Strecker; J Scott Roberts; Wylie Burke; Richard Mayeux; Thomas Bird
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.